Showing results (1311-1320 of 1,331) with videos related to

Sort By:
Pageof 134
Breast Cancer Research : BCR|June 10, 2024
Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancerRoberto A Leon-Ferre, Kaitlyn R Whitaker, Vera J Suman, et al.
JAMA Oncology|March 9, 2023
Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical TrialTufia C Haddad, Vera J Suman, Antonino B D'Assoro, et al.
Indian Journal of Ophthalmology|December 2, 2024
Initial experience with brolucizumab for neovascular age-related macular degeneration (nAMD) in India - Multicentric, real-world studyDeependra Vikram Singh, Aniruddha Agarwal, Anubhav Goyal, et al.
Cancer|April 25, 2024
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilotAmye J Tevaarwerk, Dhauna Karam, Clare A Gatten, et al.
Cell Metabolism|November 2, 2022
MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesityDong Cheng, Bradley A Zinker, Yi Luo, et al.
The Lancet. Neurology|August 16, 2025
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trialThomas O Crawford, Laurent Servais, Eugenio Mercuri, et al.
Histopathology|September 19, 2015
A multicentre validation of Metasin: a molecular assay for the intraoperative assessment of sentinel lymph nodes from breast cancer patientsPriya Sai-Giridhar, Salma Al-Ramadhani, Dilushana George, et al.
Trials|March 29, 2025
Cognitive Level Enhancement through Vision Exams and Refraction (CLEVER): study protocol for a randomised controlled trialSrinivas Marmamula, Suvarna Alladi, Keerthana Umapathy, et al.
Epilepsia|March 30, 2019
Critique of the 2017 epileptic seizure and epilepsy classificationsHans Lüders, Naoki Akamatsu, Shahram Amina, et al.
Journal of Medicinal Chemistry|October 4, 2013
Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase BManoj G Kale, Anandkumar Raichurkar, Shahul Hameed P, et al.
Pageof 134